If you made any changes in Pure these will be visible here soon.

Research Output

2019

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Open Access

Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?

Palleschi, M., Maltoni, R., Sarti, S., Melegari, E., Bravaccini, S. & Rocca, A., Jan 1 2019, (Accepted/In press) In : Breast Journal.

Research output: Contribution to journalArticle

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., 2019, In : BMC Medicine. 17, 1

Research output: Contribution to journalArticle

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, 207.

Research output: Contribution to journalArticle

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, p. 1-9 9 p., 207.

Research output: Contribution to journalArticle

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, 207.

Research output: Contribution to journalArticle

2018

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Bronte, G., Bravaccini, S., Ravaioli, S., Puccetti, M., Scarpi, E., Andreis, D., Tumedei, M. M., Sarti, S., Cecconetto, L., Pietri, E., De Simone, V., Maltoni, R., Bonafè, M., Amadori, D. & Rocca, A., Aug 1 2018, In : Translational Oncology. 11, 4, p. 950-956 7 p.

Research output: Contribution to journalArticle

Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy?

Bronte, G., Rocca, A., Ravaioli, S., Puccetti, M., Tumedei, M. M., Scarpi, E., Andreis, D., Maltoni, R., Sarti, S., Cecconetto, L., Fedeli, A., Pietri, E., De Simone, V., Asioli, S., Bravaccini, S. & Amadori, D., Mar 27 2018, In : BMC Cancer. 18, 1, 348.

Research output: Contribution to journalArticle

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

Nanni, O., Amadori, D., De Censi, A., Rocca, A., Freschi, A., Bologna, A., Gianni, L., Rosetti, F., Amaducci, L., Cavanna, L., Foca, F., Sarti, S., Serra, P., Valmorri, L., Bruzzi, P., Corradengo, D., Gennari, A., Scaltriti, L., Turolla, G. M., Dazzi, C. & 6 others, Cortesi, L., Giovanis, P., Saracchini, S., Ciccarese, M., Carrozza, F. & investigators, MYME., 2018, In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

2017

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

Rocca, A., Cecconetto, L., Passardi, A., Melegari, E., Andreis, D., Monti, M., Maltoni, R., Sarti, S., Pietri, E., Schirone, A., Fabbri, F., Donati, C., Nanni, O., Fedeli, A., Faedi, M. & Amadori, D., May 1 2017, In : Cancer Chemotherapy and Pharmacology. 79, 5, p. 863-871 9 p.

Research output: Contribution to journalArticle

2016

Androgen receptor signaling pathways as a target for breast cancer treatment

Pietri, E., Conteduca, V., Andreis, D., Massa, I., Melegari, E., Sarti, S., Cecconetto, L., Schirone, A., Bravaccini, S., Serra, P., Fedeli, A., Maltoni, R., Amadori, D., De Giorgi, U. & Rocca, A., Oct 1 2016, In : Endocrine-Related Cancer. 23, 10, p. R485-R498

Research output: Contribution to journalReview article

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. & Guarneri, V., Jul 5 2016, (Accepted/In press) In : Pharmacogenomics Journal.

Research output: Contribution to journalArticle

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D. G., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. F. & Guarneri, V., Jul 5 2016, (Accepted/In press) In : Pharmacogenomics Journal.

Research output: Contribution to journalArticle

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. & Guarneri, V., Jul 5 2016, (Accepted/In press) In : Pharmacogenomics Journal.

Research output: Contribution to journalArticle

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. & Guarneri, V., Oct 2016, In : Pharmacogenomics Journal. 16, 5, p. 472-7 6 p.

Research output: Contribution to journalArticle

2015

Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer

Rocca, A., Farolfi, A., Maltoni, R., Carretta, E., Melegari, E., Ferrario, C., Cecconetto, L., Sarti, S., Schirone, A., Fedeli, A., Andreis, D., Pietri, E., Ibrahim, T., Montalto, E. & Amadori, D., May 27 2015, In : Breast Cancer Research and Treatment. 152, 1, p. 57-65 9 p.

Research output: Contribution to journalArticle

Identification of BRAF 3'UTR isoforms in melanoma

Marranci, A., Tuccoli, A., Vitiello, M., Mercoledi, E., Sarti, S., Lubrano, S., Evangelista, M., Fogli, A., Valdes, C., Russo, F., Dal Monte, M., Caligo, M. A., Pellegrini, M., Capobianco, E., Tsinoremas, N. & Poliseno, L., Jan 1 2015, In : Journal of Investigative Dermatology. 135, 6, p. 1694-1697 4 p.

Research output: Contribution to journalArticle

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

Rocca, A., Andreis, D., Fedeli, A., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Schirone, A., Bravaccini, S., Serra, P., Farolfi, A. & Amadori, D., Oct 3 2015, In : Expert Opinion on Drug Metabolism and Toxicology. 11, 10, p. 1647-1663 17 p.

Research output: Contribution to journalArticle

Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer

Guarneri, V., Dieci, M. V., Frassoldati, A., Maiorana, A., Ficarra, G., Bettelli, S., Tagliafico, E., Bicciato, S., Generali, D. G., Cagossi, K., Bisagni, G., Sarti, S., Musolino, A., Ellis, C., Crescenzo, R. & Conte, P., Aug 5 2015, In : The oncologist. 20, 9, p. 1001-1010 10 p.

Research output: Contribution to journalArticle

2014

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy

Cecconetto, L., Gardini, A. C., Tenti, E., Maltoni, R., Bravaccini, S., Oboldi, D., Zoli, W., Serra, P., Donati, C., Sarti, S., Amadori, D. & Rocca, A., 2014, In : Tumori. 100, 3

Research output: Contribution to journalArticle

2013

The role of liposomal anthracyclines in metastatic breast cancer

Gennari, A., Piccininno, M. & Sarti, S., Mar 2013, In : Current Breast Cancer Reports. 5, 1, p. 23-30 8 p.

Research output: Contribution to journalArticle

Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors

Farolfi, A., Melegari, E., Aquilina, M., Scarpi, E., Ibrahim, T., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Ferrario, C., Fedeli, A., Faedi, M., Nanni, O., Frassineti, G. L., Amadori, D. & Rocca, A., May 2013, In : Heart. 99, 9, p. 634-639 6 p.

Research output: Contribution to journalArticle

2012

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase II CHER-LOB study

Guarneri, V., Frassoldati, A., Bottini, A., Cagossi, K., Bisagni, G., Sarti, S., Ravaioli, A., Cavanna, L., Giardina, G., Musolino, A., Untch, M., Orlando, L., Artioli, F., Boni, C., Generali, D. G., Serra, P., Bagnalasta, M., Marini, L., Piacentini, F., D'Amico, R. & 1 others, Conte, P., Jun 1 2012, In : Journal of Clinical Oncology. 30, 16, p. 1989-1995 7 p.

Research output: Contribution to journalArticle

2010

A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer

Rocca, A., Maltoni, R., Passardi, A., Massa, I., Aquilina, M., Ridolfi, R., Ibrahim, T., Cecconetto, L., Sarti, S., Pietri, E., Nanni, O. & Amadori, D., Apr 2010, In : Cancer Chemotherapy and Pharmacology. 65, 5, p. 871-876 6 p.

Research output: Contribution to journalArticle

2009

Misclassification of breast cancer as cause of death in a service screening area

Goldoni, C. A., Bonora, K., Ciatto, S., Giovannetti, L., Patriarca, S., Sapino, A., Sarti, S., Puliti, D. & Paci, E., Jul 2009, In : Cancer Causes and Control. 20, 5, p. 533-538 6 p.

Research output: Contribution to journalArticle

2007

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life

Ballatori, E., Roila, F., Ruggeri, B., Betti, M., Sarti, S., Soru, G., Cruciani, G., Di Maio, M., Andrea, B. & Deuson, R. R., Feb 2007, In : Supportive Care in Cancer. 15, 2, p. 179-185 7 p.

Research output: Contribution to journalArticle

2005

Molecular staging of the sentinel lymph node in melanoma patients: Correlation with clinical outcome

Romanini, A., Manca, G., Pellegrino, D., Murr, R., Sarti, S., Bianchi, F., AlSharif, A., Orlandini, C., Zucchi, V., Castagna, M., Gandini, D., Salimbeni, G., Ghiara, F., Barachini, P. & Mariani, G., Nov 2005, In : Annals of Oncology. 16, 11, p. 1832-1840 9 p.

Research output: Contribution to journalArticle

2003

Brain metastases from malignant melanoma

Chiarion-Sileni, V., Murr, R., Pigozzo, J., Sarti, S., Tomassi, O. & Romanini, A., 2003, In : FORUM - Trends in Experimental and Clinical Medicine. 13, 2, p. 170-185 16 p.

Research output: Contribution to journalArticle

Brain metastases from malignant melanoma.

Chiarion-Sileni, V., Murr, R., Pigozzo, J., Sarti, S., Tomassi, O. & Romanini, A., 2003, In : FORUM - Trends in Experimental and Clinical Medicine. 13, 2

Research output: Contribution to journalArticle